Narrative review / 2011
Clinical trials show resveratrol is safe and reasonably well-tolerated at doses up to 5 g/day, though mild to moderate side effects may limit dosing.
This review summarizes available clinical trial data on resveratrol, which have largely focused on characterizing its pharmacokinetics, metabolism, and safety. Recent studies evaluating multiple dosing found resveratrol to be safe and reasonably well-tolerated at doses of up to 5 g/day. However, the occurrence of mild to moderate side effects is likely to limit future trial doses to significantly less than 5 g/day.
- Study type
- Narrative review of clinical trials
- Who was studied
- Human participants in published clinical trials
- What was measured
- Pharmacokinetics, metabolism, safety, tolerability, and mechanisms of activity
THE PAPER
Clinical trials of resveratrol.
Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Ann N Y Acad Sci, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.